Covid situation in control, no need to panic: PMC
On Monday, the PMC held a review meeting to assess the Covid-19 situation in the city. The meeting was chaired by additional municipal commissioner M J Pradeep Chandran, and attended by representatives from the PMC health department, public health officials, and the Rapid Response Task Force. Experts from key institutions such as the National Chemical Laboratory (NCL), National Institute of Virology (NIV), B J Medical College (BJMC), and private hospitals also attended the meeting, according to officials. The RRT members said that the current virus strain in circulation is mild and no deaths have been reported in the city. The PMC till date has sent 145 Covid samples for genome sequencing and no new variant has been found. Besides, patients hospitalised with influenza-like illness (ILI) and severe acute respiratory infection (SARI) will be tested for Covid.
Dr Nina Borade, health chief of the PMC, said, 'The Covid situation in the city is under control and the situation is not alarming. However, experts have stressed that individuals in high-risk categories, with existing co-morbid conditions should take precautions. We have asked all private hospitals to test SARI and ILI patients for Covid.'
As per the statement issued by the public health department, Maharashtra on Monday reported 65 fresh Covid cases with 26 from areas under the PMC, 22 from Mumbai, and two from areas under the Pimpri-Chinchwad Municipal Corporation (PCMC). Since January, 1,504 Covid cases and 18 deaths amongst the infected have been reported. Furthermore, there are 613 active Covid-19 cases in the state. Since January, Mumbai has reported 687 cases, 681 of which were reported in May alone, said Dr Babita Kamlapurkar, joint director of health services.
Dr Kamlapurkar said that instructions have been issued to all officers in the divisional, district, and municipal corporations across the state during the Covid-19 review meeting. 'Surveillance for ILI and SARI patients is being conducted regularly, with 5% of these patients being asked to undergo testing for Covid-19. All Covid-positive samples are sent for whole genome sequencing. Additionally, all healthcare facilities under the public health department, medical colleges within the medical education department, and hospitals and medical colleges in urban areas are directed to be prepared for Covid-19 testing and treatment,' she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
PM Modi urges scientists to focus on R&D, secure patents for new drugs
Prime Minister Narendra Modi on Friday urged scientists and entrepreneurs to focus more on research and development (R&D) and secure patents for new drugs and medical technologies to ensure self-reliance in the pharmaceutical segment. Speaking from the Red Fort on the occasion of India's 79th Independence Day, Modi said this would enable the country not only to meet its own healthcare needs but also to emerge as a global hub of medical innovation. The call comes at a time when India has been lagging in R&D spending, according to a Department of Pharmaceuticals (DoP) study paper on industry–academia linkage in the segment. The paper states that while a number of initiatives for industry–academic linkages in India have produced positive research results over the years, their sporadic nature has kept India's share of world researchers at about 2 per cent, compared to 20 per cent in the United States and China. 'An analysis of the share in R&D reveals that in India, the government contributes between 75 and 80 per cent, the private sector 20 to 25 per cent, and universities 3 per cent,' the paper noted. In comparison, OECD countries see 69 per cent of R&D funding from private sector companies, followed by universities at 18 per cent, government at 10 per cent, and non-profit organisations at 3 per cent. Calling on industry to demonstrate India's ability to lead in science, technology, and human welfare, Modi also urged the nation to achieve self-reliance in medicines and innovation, highlighting the country's role as the pharmacy of the world. India currently has around 3,000 pharmaceutical businesses with over 10,500 manufacturing facilities, offering about 60,000 generic brands in 60 therapeutic categories. Many Indian pharmaceutical companies are now pursuing opportunities in generic production for off-patent molecules while building biosimilars pipelines after the Covid-19 pandemic. Pharma firms have stepped up generic launches after several blockbuster molecules used in diabetes medications, such as empagliflozin and dapagliflozin, went off patent in the past two years. Prices of these drugs have fallen by as much as 85 per cent in the Indian market. Similarly, companies such as Sun Pharma, Torrent, Lupin, Glenmark, and Dr Reddy's are working on generic versions of weight-loss drugs based on the blockbuster molecule semaglutide, which is expected to go off patent by March 2026. According to the DoP study paper, more than 300 drug patents across different categories and geographies are set to expire every year during the 'patent cliff' period from 2022 to 2032. 'The patent cliff will provide an opportunity for Indian generic companies to enter the US and other regulated markets and produce more affordable versions of those medications,' the paper added.
Indian Express
12 hours ago
- Indian Express
Lok Nayak Hospital's neurosurgery ICU gets 5 portable ventilators
Lok Nayak Hospital's neurosurgery department on Thursday installed five portable ventilators at its ICU unit and secured three ventilator beds of ICU units of other departments for its patients. Portable or transport ventilators are mechanical ventilation devices designed specifically for emergency or transport scenarios, while fixed ventilators are permanently positioned respiratory support. This comes after The Indian Express reported on Thursday that as per official records, only one of the 15 ventilators was functional in the neurosurgery department of the Delhi's government's 2,153-bed Lok Nayak Hospital — the largest such facility in the national capital. Weekly status reports maintained by the hospital showed that there were 14 ventilators in the department till Tuesday — none of them functional. One functional ventilator was added on Wednesday. According to records, ten of these ventilators have been non-functional for eight months, two for about a year and two more for over two years. In 12 of these ventilators, 'multiple spares are defective' and need to be 'replaced as per service report'. The two ventilators that have been non-functional for over two years were procured during Covid from the PM CARES Fund. Delhi Health Minister Pankaj Kumar Singh and Lok Nayak Hospital Director B L Chaudhary did not respond to queries from The Indian Express regarding the ventilators. Official sources said that Danish Ashraf, Special Secretary, Delhi Health and Family Welfare department, visited the hospital around 3 pm on Thursday for an inspection of the neurosurgery department's ICU. 'Medical Director Dr B L Chaudhary was also on round,' the official source said. The hospital also procured 18 ventilators from Rajiv Gandhi Super Speciality Hospital that are yet to be installed. Sources in the hospital said the instructions have been issued to repair the existing ventilators in the next 10 days. An official said: 'Instructions related to repair and maintenance of ventilators were passed earlier as well. Now, another set of instructions have been issued to speed up the process. We coordinate with manufacturing firms for annual maintenance of the machines.' Sources in the department also said that a lack of ventilators for almost a year led to a drop in the number of surgeries performed each month. Before the ventilators stopped working, an average of 30-35 elective surgeries and 20-25 emergency neurosurgeries were conducted in two operation theatres every month, the sources said. 'The number has come down to an average of 20 elective and 10 emergency surgeries per month… Cases are being prioritised and shortlisted. Cases which do not require ventilation are preferred,' said a senior doctor. Sources also said that patients who are operated upon in the neurosurgery department and require ventilator support were being shifted to the general surgery department's ICU, which has 15 ventilator beds. This ICU also accommodates patients who have undergone surgeries in the orthopaedic and medicine departments.
Hindustan Times
12 hours ago
- Hindustan Times
MBBS cutoffs in Maharashtra drop sharply as merit list announced
MUMBAI: Cutoff marks for MBBS admissions in Maharashtra have fallen significantly this year, with the State Common Entrance Test (CET) Cell attributing the slide to a tougher NEET paper and smoother seat approvals. MBBS cutoffs in Maharashtra drop sharply as merit list announced The CET Cell released the first merit list for 2025 on Thursday, showing the open-category cutoff for government medical colleges at 509 marks — down from 642 last year. In private unaided colleges, the cutoff dropped to 479 from 602. The CET Cell is conducting admissions for 8,138 MBBS seats across 64 colleges in the state. Officials said the decline is evident in both government and private institutions. While last year's higher cutoffs were partly due to an easier NEET paper, this year's exam — particularly its physics section — was considered more challenging. Experts noted that NEET's difficulty had been reduced during the COVID-19 years but has now reverted to pre-pandemic levels, depressing overall scores. Parents' representative Sudha Shenoy welcomed the trend, saying it would allow more students to secure government seats. She credited timely approvals for medical colleges — completed before the first merit list for the first time — as a key factor. 'This clarity reduced uncertainty and helped bring cutoffs down,' she said, adding that in previous years, delays in approvals often pushed up the first-list benchmarks.
